Galderma Laboratories L.P.'s pending launch of Differin Gel 0.1% could push parent firm Nestle SA to the top of the OTC acne treatment market following the Swiss firm's recent investment in a joint venture that will market the current category leader, Proactiv.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?